ProShare Advisors LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$872,000
+125.9%
12,797
+6.0%
0.00%
+200.0%
Q2 2022$386,000
-39.1%
12,069
-34.1%
0.00%0.0%
Q1 2022$634,000
-4.2%
18,324
-19.0%
0.00%0.0%
Q4 2021$662,000
+23.7%
22,609
+7.6%
0.00%
-50.0%
Q3 2021$535,000
-42.8%
21,006
-21.4%
0.00%
-33.3%
Q2 2021$936,000
+167.4%
26,714
+210.6%
0.00%
+200.0%
Q1 2021$350,000
-15.3%
8,600
-9.8%
0.00%
-50.0%
Q4 2020$413,000
-24.2%
9,537
-3.6%
0.00%
-33.3%
Q3 2020$545,000
-11.4%
9,889
+1.6%
0.00%0.0%
Q2 2020$615,000
+3.0%
9,736
-16.7%
0.00%
-25.0%
Q1 2020$597,000
-64.0%
11,682
-44.0%
0.00%
-50.0%
Q4 2019$1,660,000
+49.8%
20,877
-8.6%
0.01%
+33.3%
Q3 2019$1,108,000
-4.8%
22,845
+3.2%
0.01%
-14.3%
Q2 2019$1,164,000
-11.9%
22,134
-11.3%
0.01%
-12.5%
Q1 2019$1,321,000
+40.1%
24,955
+8.7%
0.01%
+14.3%
Q4 2018$943,000
-9.2%
22,968
-16.0%
0.01%0.0%
Q3 2018$1,039,000
-19.0%
27,342
-3.6%
0.01%
-22.2%
Q2 2018$1,282,000
-0.8%
28,360
+6.1%
0.01%
+12.5%
Q1 2018$1,292,000
+13.1%
26,740
-7.9%
0.01%0.0%
Q4 2017$1,142,000
+35.3%
29,023
+6.8%
0.01%0.0%
Q3 2017$844,000
+20.2%
27,187
+6.0%
0.01%
+14.3%
Q2 2017$702,000
-12.7%
25,649
+17.5%
0.01%
-12.5%
Q1 2017$804,000
+103.5%
21,822
-20.1%
0.01%
+100.0%
Q4 2016$395,00027,3120.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders